News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
HOWSON TAMAR D
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2023 |
4
| HOWSON TAMAR D (Director) has filed a Form 4 on IMMUNIC, INC.|
Txns:
| Granted 16,000 options
@ $1.94, valued at
$31k
|
|
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| HOWSON TAMAR D (Director) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Granted 10,000 options to buy
@ $12.28, valued at
$122.8k
|
|
| 07/06/2021 |
4
| HOWSON TAMAR D (Director) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 50,000 options to buy
@ $2.95, valued at
$147.5k
|
|
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| HOWSON TAMAR D (Director) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Granted 10,000 options to buy
@ $12.36, valued at
$123.6k
|
|
| 09/18/2020 |
4
| HOWSON TAMAR D (Director) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Granted 50,000 options to buy
@ $17.21, valued at
$860.5k
|
|
| 09/18/2020 |
3
| HOWSON TAMAR D (Director) has filed a Form 3 on Cue Biopharma, Inc. |
| 07/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/15/2019 |
4
| HOWSON TAMAR D (Director) has filed a Form 4 on IMMUNIC, INC.|
Txns:
| Granted 29,959 options
@ $9.54, valued at
$285.8k
|
|
| 10/15/2019 |
3
| HOWSON TAMAR D (Director) has filed a Form 3 on IMMUNIC, INC. |
| 07/03/2019 |
4
| HOWSON TAMAR D (Director) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 60,000 options to buy
@ $2.52, valued at
$151.2k
|
|
| 07/03/2019 |
3
| HOWSON TAMAR D (Director) has filed a Form 3 on MEI Pharma, Inc. |
| 07/30/2018 |
4
| HOWSON TAMAR D (Director) has filed a Form 4 on ORGANOVO HOLDINGS, INC.|
Txns:
| Granted 45,500 options to buy
@ $1.29, valued at
$58.7k
|
|
| 08/28/2017 |
4
| HOWSON TAMAR D (Director) has filed a Form 4 on ORGANOVO HOLDINGS, INC.|
Txns:
| Granted 42,500 options to buy
@ $1.97, valued at
$83.7k
|
|
| 04/11/2017 |
4
| HOWSON TAMAR D (Director) has filed a Form 4 on ContraVir Pharmaceuticals, Inc. |
| 12/15/2016 |
3
| HOWSON TAMAR D (Director) has filed a Form 3 on ContraVir Pharmaceuticals, Inc. |
| 08/19/2016 |
4
| HOWSON TAMAR D (Director) has filed a Form 4 on ORGANOVO HOLDINGS, INC. |
| 08/24/2015 |
4
| HOWSON TAMAR D (Director) has filed a Form 4 on ORGANOVO HOLDINGS, INC.|
Txns:
| Granted 37,000 options to buy
@ $2.09, valued at
$77.3k
|
|
| 05/29/2015 |
4
| HOWSON TAMAR D (Director) has filed a Form 4 on OXIGENE INC|
Txns:
| Granted 77,996 options to buy
@ $1.43, valued at
$111.5k
|
|
| 03/19/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/26/2014 |
4
| HOWSON TAMAR D (Director) has filed a Form 4 on ORGANOVO HOLDINGS, INC.|
Txns:
| Granted 31,500 options to buy
@ $7.62, valued at
$240k
|
|
| 08/05/2014 |
4
| HOWSON TAMAR D (Director) has filed a Form 4 on IDENIX PHARMACEUTICALS INC|
Txns:
| Disposed/sold 15,000 options to buy
@ $2.79, valued at
$41.9k
Disposed/sold 3,333 options to buy
@ $2.79, valued at
$9.3k
Disposed/sold 20,000 options to buy
@ $4.09, valued at
$81.8k
Disposed/sold 20,000 options to buy
@ $4.57, valued at
$91.4k
Disposed/sold 20,000 options to buy
@ $9.03, valued at
$180.6k
Disposed/sold 20,000 options to buy
@ $4.94, valued at
$98.8k
Disposed/sold 20,000 options to buy
@ $6.88, valued at
$137.6k
|
|
| 07/07/2014 |
4
| HOWSON TAMAR D (Director) has filed a Form 4 on OXIGENE INC|
Txns:
| Granted 5,280 options to buy
@ $2.6, valued at
$13.7k
|
|
| 06/06/2014 |
4
| HOWSON TAMAR D (Director) has filed a Form 4 on IDENIX PHARMACEUTICALS INC|
Txns:
| Granted 20,000 options to buy
@ $6.88, valued at
$137.6k
|
|
| 05/13/2014 |
4
| HOWSON TAMAR D (Director) has filed a Form 4 on Actavis plc|
Txns:
| Granted 1,142 shares
@ $197.05, valued at
$225k
|
|
| 01/06/2014 |
4
| HOWSON TAMAR D (Director) has filed a Form 4 on OXIGENE INC|
Txns:
| Granted 4,880 options to buy
@ $2.79, valued at
$13.6k
|
|
| 11/08/2013 |
4
| HOWSON TAMAR D (Director) has filed a Form 4 on Actavis plc|
Txns:
| Sold 300 shares
@ $157.34, valued at
$47.2k
|
|
| 10/03/2013 |
4
| HOWSON TAMAR D (Director) has filed a Form 4 on Actavis plc|
Txns:
| Granted 1,246 shares
@ $0 |
|
| 10/03/2013 |
3
| HOWSON TAMAR D (Director) has filed a Form 3 on Actavis plc |
|
|
|